Evidence map›Paper›PMID 36574090›Full record

ArticleApoptosis : an international journal on programmed cell death2023

circTAB2 inhibits lung cancer proliferation, migration and invasion by sponging miR-3142 to upregulate GLIS2.

Weiling Man, Yumeng Cui, Jie Li, Yanghua Li, Jie Jin, Yang Jin, Xiaojie Wu, Rongbin Zhong, Xiang Li, He Yao and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Apoptosis : an international journal on programmed cell death, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. circHERC1-A telomerase activator.Science advances · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Circular RNAs and Cancers.Advances in experimental medicine and biology · 2025
    Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Weiling Man *Medical College, Guangxi University, Nanning, 530004, China.
Yumeng Cui *Beijing Institute of Biotechnology, Beijing, 100071, China.
Jie LiDepartment of Thoracic Surgery, The First Medical Center of Chinese, PLA General Hospital, Beijing, 100063, China.
Yanghua LiMedical College, Guangxi University, Nanning, 530004, China.
Jie JinBeijing Institute of Biotechnology, Beijing, 100071, China.
Yang Jin920Th Hospital of Joint Logistic Support Force, PLA, Kunming, 650032, China.
Xiaojie WuBeijing Institute of Biotechnology, Beijing, 100071, China.
Rongbin ZhongBeijing Institute of Biotechnology, Beijing, 100071, China.
Xiang LiBeijing Institute of Biotechnology, Beijing, 100071, China.
He YaoBeijing Institute of Biotechnology, Beijing, 100071, China.
Yanli LinBeijing Institute of Biotechnology, Beijing, 100071, China. linyl1089@163.com.
Lihe JiangMedical College, Guangxi University, Nanning, 530004, China. jianglihe@gxu.edu.cn.
Youliang WangBeijing Institute of Biotechnology, Beijing, 100071, China. wangyouliang@bmi.ac.cn.
Guangxi University · CNAffiliated Hospital of Youjiang Medical University for Nationalities · CNChinese PLA General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circular RNAs (circRNAs) are a specialized circular structure, are deregulated in cancers and play essential roles in biological processes involved in tumor progression. However, the mechanism by which circRNAs affect lung tumorigenesis and progression remains largely unexplored. To investigate the role of circRNA in lung cancer, circRNA expression profile was screened by bioinformatics analysis. The levels of circTAB2, miR-3142, and GLIS family zinc finger 2 (GLIS2) were measured by quantitate real-time (qRT-PCR) or western blot. Cell proliferation, apoptosis, migration and invasion were detected by EdU, flow cytometry, and transwell assays, respectively. Bioinformatics, western blot, RIP, pull down, dual luciferase reporter and rescue experiments were used to verify the direct relationship between miR-3142 and circTAB2 or GLIS2. The xenograft assays were used to assess the role of circTAB2 in vivo.CircTAB2 exhibited low expression in cancer tissues. Gain and loss-of-function assays indicated that circTAB2 could inhibit cell proliferation, migration and invasion. Functional studies revealed that circTAB2 acted as a miRNA sponge, directly interacted with miR-3142 and consequently regulated GLIS2 /AKT. Taken together, circTAB2 serves as an inhibitory role in lung cancer through a novel circTAB2 /miR-3142 /GLIS2 /AKT pathway and could be exploited a novel marker in lung cancer.

Indexed as

Lung NeoplasmsMicroRNAsApoptosisCell Line, TumorCell ProliferationFungal ProteinsGene Expression Regulation, NeoplasticHumansProteoglycansProto-Oncogene Proteins c-aktRNA, CircularFungal ProteinsGLIS protein, Ganoderma lucidumMicroRNAsProteoglycansProto-Oncogene Proteins c-aktRNA, CircularcircRNAGLIS2Lung cancermiR−3142

Identifiers

PMID36574090
OpenAlexW4312211719

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.